Pirh2 E3 ubiquitin ligase targets DNA polymerase eta for 20S proteasomal degradation

Yong-Sam Jung1, Gang Liu, Xinbin Chen

  • 1Center for Comparative Oncology, University of California, Davis, California 95616, USA.

Insights

DNA polymerase eta (PolH) protein stability is regulated by UV irradiation and the Pirh2 E3 ligase. PolH degradation by the proteasome is enhanced by UV, impacting skin cancer risk in xeroderma pigmentosum variant patients.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Biochemistry

Background:

  • DNA polymerase eta (PolH) is crucial for repairing UV-induced DNA damage and preventing skin cancer in xeroderma pigmentosum variant (XPV) patients.
  • Loss of PolH function is linked to early-onset malignant skin cancers.
  • PolH is a target of the p53 tumor suppressor and has a short half-life.

Purpose of the Study:

  • To investigate the regulation of PolH protein stability.
  • To identify the mechanisms and factors involved in PolH degradation.
  • To understand the role of PolH regulation in cellular response to UV damage and cancer development.

Main Methods:

  • Assessing PolH protein stability under various conditions.
  • Investigating PolH interaction with the Pirh2 E3 ligase using co-immunoprecipitation.
  • Analyzing the effect of Pirh2 overexpression and knockdown on PolH stability.
  • Examining PolH degradation by the 20S proteasome in a ubiquitin-independent manner.
  • Evaluating the impact of Pirh2 knockdown on UV-irradiated cell survival.

Main Results:

  • PolH is a short-half-life protein degraded by the proteasome, with degradation enhanced upon UV irradiation.
  • PolH interacts with the Pirh2 E3 ligase via specific protein domains.
  • Pirh2 overexpression decreases PolH stability, while Pirh2 knockdown increases it.
  • PolH is degraded by the 20S proteasome in a ubiquitin-independent manner, facilitated by Pirh2.
  • Pirh2 knockdown results in PolH accumulation and enhanced survival of UV-irradiated cells.

Conclusions:

  • UV irradiation promotes cancer formation by destabilizing PolH through Pirh2-mediated 20S proteasomal degradation.
  • The Pirh2-PolH interaction represents a novel regulatory pathway impacting DNA repair and cancer susceptibility.
  • Targeting the Pirh2-mediated degradation of PolH may offer therapeutic strategies for skin cancer prevention and treatment.

Related Concept Videos

The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
The Proteasome Structure01:17

The Proteasome Structure

The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
Eukaryotic RNA Polymerases00:58

Eukaryotic RNA Polymerases

RNA Polymerase (RNAP) is conserved in all animals, with bacterial, archaeal, and eukaryotic RNAPs sharing significant sequence, structural, and functional similarities. Among the three eukaryotic RNAPs, RNA Polymerase II is most similar to bacterial RNAP in terms of both structural organization and folding topologies of the enzyme subunits. However, these similarities are not reflected in their mechanism of action.
All three eukaryotic RNAPs require specific transcription factors, of which the...